Ignite Creation Date:
2025-12-25 @ 3:44 AM
Ignite Modification Date:
2025-12-26 @ 2:29 AM
Study NCT ID:
NCT02568202
Status:
COMPLETED
Last Update Posted:
2016-01-12
First Post:
2015-09-18
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Bridging Hemophilia B Experiences, Results and Opportunities Into Solutions (B-HERO-S)
Sponsor:
Novo Nordisk A/S
Organization:
Study Overview
Official Title:
Bridging Hemophilia B Experiences, Results and Opportunities Into Solutions (B-HERO-S)
Status:
COMPLETED
Status Verified Date:
2016-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is conducted in the United States of America (USA). Tha aim of this study is bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B-HERO-S).
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| U1111-1171-8168 | OTHER | WHO | View |